Mads Liebach Bjerregaard Management

Roles

SynAct Pharma AB Stockholm
Management
05.03.202605.03.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
05.03.2026SynAct Pharma AB Stockholm
Bought — open marketAcquisition
1,500SEK 17.92
SEK 26,880.00